TickerFacts.

A business in context

INBX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-14 · 0001366074-26-000006

  2. 8-K · Current report

    Report date 2026-09-28 · 0002007919-26-000050 · Items 7.01,9.01

  3. 4 · Ownership change

    Report date 2026-09-25 · 0001366074-26-000004

  4. 4 · Ownership change

    Report date 2026-09-23 · 0001366268-26-000011

  5. 4/A · Ownership change

    Report date 2026-06-03 · 0001612627-26-000007

  6. 4/A · Ownership change

    Report date 2026-06-03 · 0001366268-26-000009

  7. 4/A · Ownership change

    Report date 2026-06-03 · 0001240801-26-000006

  8. 4/A · Ownership change

    Report date 2026-06-03 · 0001202094-26-000009

  9. 4 · Ownership change

    Report date 2026-09-16 · 0001366268-26-000006

  10. 8-K · Current report

    Report date 2026-09-08 · 0002007919-26-000047 · Items 7.01,8.01,9.01

  11. 8-K · Current report

    Report date 2026-08-13 · 0002007919-26-000044 · Items 2.02,9.01

  12. 10-Q · Quarterly report

    Report date 2026-06-30 · 0002007919-26-000042

  13. 8-K · Current report

    Report date 2026-07-15 · 0002007919-26-000037 · Items 1.01,2.03,3.02,7.01,9.01

  14. 8-K · Current report

    Report date 2026-06-15 · 0002007919-26-000033 · Items 7.01,8.01,9.01

  15. 8-K · Current report

    Report date 2026-06-03 · 0002007919-26-000030 · Items 5.07

  16. 8-K · Current report

    Report date 2026-05-14 · 0002007919-26-000028 · Items 2.02,9.01

  17. 10-Q · Quarterly report

    Report date 2026-03-31 · 0002007919-26-000027

  18. 8-K · Current report

    Report date 2026-05-11 · 0002007919-26-000020 · Items 7.01,8.01,9.01

  19. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0002007919-26-000014

  20. 8-K · Current report

    Report date 2026-04-21 · 0002007919-26-000010 · Items 7.01,8.01,9.01

  21. 8-K · Current report

    Report date 2026-03-19 · 0002007919-26-000007 · Items 2.02,9.01

  22. 10-K · Annual report

    Report date 2025-12-31 · 0002007919-26-000006

  23. 8-K · Current report

    Report date 2026-02-23 · 0002007919-26-000002 · Items 7.01,9.01

  24. 8-K · Current report

    Report date 2025-12-16 · 0002007919-25-000097 · Items 7.01,8.01,9.01

  25. 8-K · Current report

    Report date 2025-11-14 · 0002007919-25-000094 · Items 2.02,9.01

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0002007919-25-000093

  27. 8-K · Current report

    Report date 2025-10-23 · 0002007919-25-000089 · Items 7.01,8.01,9.01

  28. 8-K · Current report

    Report date 2025-08-13 · 0002007919-25-000083 · Items 2.02,9.01

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0002007919-25-000081

  30. 8-K · Current report

    Report date 2025-05-28 · 0002007919-25-000063 · Items 5.07

  31. 8-K · Current report

    Report date 2025-05-14 · 0002007919-25-000057 · Items 2.02,9.01

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0002007919-25-000056

  33. DEF 14A · Proxy statement

    Report date 2024-12-31 · 0002007919-25-000043

  34. 8-K · Current report

    Report date 2025-03-31 · 0002007919-25-000028 · Items 5.02

  35. 8-K · Current report

    Report date 2025-03-17 · 0002007919-25-000020 · Items 2.02,9.01

  36. 10-K · Annual report

    Report date 2024-12-31 · 0002007919-25-000019

  37. 8-K · Current report

    Report date 2025-01-21 · 0002007919-25-000007 · Items 7.01,8.01,9.01

  38. 8-K · Current report

    Report date 2025-01-13 · 0002007919-25-000003 · Items 1.01,2.03,3.02,7.01,9.01

  39. 8-K · Current report

    Report date 2024-11-14 · 0002007919-24-000060 · Items 2.02,9.01

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0002007919-24-000058

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 14 transaction rows14PSale: 5 transaction rows5SGrant / award: 4 transaction rows4AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

23 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-28
2026-09-28
Lappe MarkP · Purchase
Acquired
Common Stock1500.098.88
2026-09-28
2026-09-28
Lappe MarkP · Purchase
Acquired
Common Stock3000.0101.7
2026-09-25
2026-09-28
Lappe MarkP · Purchase
Acquired
Common Stock3324.098.87
2026-09-25
2026-09-28
Lappe MarkP · Purchase
Acquired
Common Stock2176.099.6
2026-09-23
2026-09-23
Kayyem Jon FaizP · Purchase
Acquired
Common Stock5000.0100.0
2026-09-16
2026-09-17
Kayyem Jon FaizP · Purchase
Acquired
Common Stock5000.0100.0
2026-09-15
2026-09-15
MANHARD KIMBERLYS · Sale
Disposed
Common Stock500.0105.05
2026-09-14
2026-09-15
MANHARD KIMBERLYS · Sale
Disposed
Common Stock500.0110.26
2026-09-11
2026-09-15
MANHARD KIMBERLYS · Sale
Disposed
Common Stock500.0111.78
2026-09-09
2026-09-10
MANHARD KIMBERLYS · Sale
Disposed
Common Stock500.0115.8
2026-09-08
2026-09-08
Kayyem Jon FaizP · Purchase
Acquired
Common Stock5000.0113.52
2026-09-08
2026-09-08
Lappe MarkP · Purchase
Acquired
Common Stock500.0108.24
2026-09-08
2026-09-08
Lappe MarkP · Purchase
Acquired
Common Stock9681.0112.28
2026-09-08
2026-09-08
Lappe MarkP · Purchase
Acquired
Common Stock1219.0111.88
2026-09-08
2026-09-08
Lappe MarkP · Purchase
Acquired
Common Stock5895.099.29
2026-09-08
2026-09-08
Lappe MarkP · Purchase
Acquired
Common Stock6605.0100.64
2026-09-08
2026-09-08
Lappe MarkP · Purchase
Acquired
Common Stock1100.0107.12
2026-09-08
2026-09-08
FORSYTH DOUGLASP · Purchase
Acquired
Common Stock2500.0114.65
2026-09-08
2026-09-10
MANHARD KIMBERLYS · Sale
Disposed
Common Stock500.0115.14
2026-06-03
2026-09-18 · Amendment
Vuori Kristiina MDA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
10000.00.0
2026-06-03
2026-09-18 · Amendment
Kayyem Jon FaizA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
10000.00.0
2026-06-03
2026-09-18 · Amendment
FORSYTH DOUGLASA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
10000.00.0
2026-06-03
2026-09-18 · Amendment
MANHARD KIMBERLYA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
10000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0002007919Inhibrx Biosciences, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$200.0K$214.8K
    2023-12-31$1.80M$1.99M

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗